{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T02:07:18Z","timestamp":1768097238136,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The intent of this study was to investigate if cerebrospinal fluid (CSF) from autoimmune encephalitis (AE) patients regulates <jats:italic>in vitro<\/jats:italic> neuronal network activity differentially to healthy human control CSF (hCSF). To this end, electrophysiological effects of CSF from AE patients or hCSF were measured by <jats:italic>in vitro<\/jats:italic> neuronal network activity (ivNNA) recorded with microelectrode arrays (MEA). CSF from patients with either N-methyl-D-aspartate-receptor-antibody (pCSF<jats:sup>NMDAR<\/jats:sup>, n\u2009=\u20097) or Leucine-rich-glioma-inactivated-1-Ab (pCSF<jats:sup>LGI1<\/jats:sup>, n\u2009=\u20096) associated AE suppressed global spiking activity of neuronal networks by a factor of 2.17 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) or 2.42 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) compared to hCSF. The former also suppressed synchronous network bursting by a factor of 1.93 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) in comparison to hCSF (n\u2009=\u200913). As a functional diagnostic test, this parameter reached a sensitivity of 86% for NMDAR-Ab- and 100% for LGI1-Ab-associated AE vs. hCSF at a specificity of 85%. To explore if modulation at the NMDAR influences effects of hCSF or pathological CSF, we applied the NMDAR-antagonist 2-Amino-5-phosphono-pentanoic acid (AP5). In CSF from NMDAR-Ab-associated AE patients, spike rate reduction by AP5 was more than 2-fold larger than in hCSF (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), and network burst rate reduction more than 18-fold (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). Recording ivNNA might help discriminating between functional effects of CSF from AE patients and hCSF, and thus could\u00a0be used as a functional diagnostic test in AE. The pronounced suppression of ivNNA by CSF from NMDAR-Ab-associated AE patients and simultaneous antagonism at the NMDAR by AP5, particularly in burst activity, compared to hCSF plus AP5, confirms that the former contains additional ivNNA-suppressing factors.<\/jats:p>","DOI":"10.1038\/s41598-019-41849-z","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T10:17:37Z","timestamp":1554286657000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["In vitro neuronal network activity as a new functional diagnostic system to detect effects of Cerebrospinal fluid from autoimmune encephalitis patients"],"prefix":"10.1038","volume":"9","author":[{"given":"Henner","family":"Koch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina E.","family":"Niturad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Theiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian G.","family":"Bien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2531-6701","authenticated-orcid":false,"given":"Christian","family":"Elger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus-Peter","family":"Wandinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Malter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"K\u00f6rtvelyessy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Lerche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Dihn\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,3]]},"reference":[{"key":"41849_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus, F. et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 15, 391\u2013404 (2016).","journal-title":"Lancet Neurol."},{"key":"41849_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.5698\/1535-7511.17.3.134","volume":"17","author":"CG Bien","year":"2017","unstructured":"Bien, C. G. & Holtkamp, M. Autoimmune Epilepsy: Encephalitis With Autoantibodies for Epileptologists. Epilepsy Curr 17, 134\u2013141 (2017).","journal-title":"Epilepsy Curr"},{"key":"41849_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.14581\/jer.16010","volume":"6","author":"SK Lee","year":"2016","unstructured":"Lee, S. K. & Lee, S.-T. The Laboratory Diagnosis of Autoimmune Encephalitis. J. epilepsy Res. 6, 45\u201350 (2016).","journal-title":"J. epilepsy Res."},{"key":"41849_CR4","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/ana.410270515","volume":"27","author":"J Dalmau","year":"1990","unstructured":"Dalmau, J., Furneaux, H. M., Gralla, R. J., Kris, M. G. & Posner, J. B. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer? A quantitative western blot analysis. Ann. Neurol. 27, 544\u2013552 (1990).","journal-title":"Ann. Neurol."},{"key":"41849_CR5","doi-asserted-by":"publisher","unstructured":"Dalmau, J. et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol., https:\/\/doi.org\/10.1016\/S1474-4422(08)70224-2 (2008).","DOI":"10.1016\/S1474-4422(08)70224-2"},{"key":"41849_CR6","doi-asserted-by":"crossref","unstructured":"Schwarz, N. et al. Human Cerebrospinal fluid promotes long-term neuronal viability and network function in human neocortical organotypic brain slice cultures. Sci. Rep. 7 (2017).","DOI":"10.1038\/s41598-017-12527-9"},{"key":"41849_CR7","first-page":"1","volume":"10","author":"M Perez-Alcazar","year":"2016","unstructured":"Perez-Alcazar, M. et al. Human Cerebrospinal Fluid Promotes Neuronal Viability and Activity of Hippocampal Neuronal Circuits. In Vitro. Front. Cell. Neurosci. 10, 1\u201311 (2016).","journal-title":"In Vitro. Front. Cell. Neurosci."},{"key":"41849_CR8","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1097\/WNR.0000000000000890","volume":"28","author":"S Theiss","year":"2017","unstructured":"Theiss, S. et al. Dementia with Lewy bodies. Neuroreport 28, 1061\u20131065 (2017).","journal-title":"Neuroreport"},{"key":"41849_CR9","doi-asserted-by":"publisher","unstructured":"Otto, F. et al. Cerebrospinal fluid of brain trauma patients inhibits in vitro neuronal network function via NMDA receptors. Ann. Neurol., https:\/\/doi.org\/10.1002\/ana.21808 (2009).","DOI":"10.1002\/ana.21808"},{"key":"41849_CR10","doi-asserted-by":"publisher","unstructured":"Jantzen, S. U. et al. In vitro neuronal network activity in NMDA receptor encephalitis. BMC Neurosci., https:\/\/doi.org\/10.1186\/1471-2202-14-17 (2013).","DOI":"10.1186\/1471-2202-14-17"},{"key":"41849_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncir.2018.00005","volume":"12","author":"A Bjorefeldt","year":"2018","unstructured":"Bjorefeldt, A., Illes, S., Zetterberg, H. & Hanse, E. Neuromodulation via the Cerebrospinal Fluid: Insights from Recent in Vitro Studies. Front. Neural Circuits 12, 1\u201312 (2018).","journal-title":"Front. Neural Circuits"},{"key":"41849_CR12","doi-asserted-by":"crossref","unstructured":"Jahn, K., Franke, C. & Bufler, J. Mechanism of block of nicotinic acetylcholine receptor channels by purified IgG from seropositive patients with myasthenia gravis. Neurology (2000).","DOI":"10.1212\/WNL.54.2.474"},{"key":"41849_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/ana.24195","volume":"76","author":"EH Moscato","year":"2014","unstructured":"Moscato, E. H. et al. Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis. Ann. Neurol. 76, 108\u2013119 (2014).","journal-title":"Ann. Neurol."},{"key":"41849_CR14","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1093\/brain\/aww208","volume":"139","author":"J Kreye","year":"2016","unstructured":"Kreye, J. et al. Human cerebrospinal fluid monoclonal N -methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis. Brain 139, 2641\u20132652 (2016).","journal-title":"Brain"},{"key":"41849_CR15","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","volume":"30","author":"EG Hughes","year":"2010","unstructured":"Hughes, E. G. et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J. Neurosci. 30, 5866\u201375 (2010).","journal-title":"J. Neurosci."},{"key":"41849_CR16","doi-asserted-by":"publisher","first-page":"11082","DOI":"10.1523\/JNEUROSCI.0064-12.2012","volume":"32","author":"AJ Gleichman","year":"2012","unstructured":"Gleichman, A. J., Spruce, L. A., Dalmau, J., Seeholzer, S. H. & Lynch, D. R. Anti-NMDA Receptor Encephalitis Antibody Binding Is Dependent on Amino Acid Identity of a Small Region within the GluN1 Amino Terminal Domain. J. Neurosci. 32, 11082\u201311094 (2012).","journal-title":"J. Neurosci."},{"key":"41849_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1113\/jphysiol.2007.130617","volume":"582","author":"C Morgado-Valle","year":"2007","unstructured":"Morgado-Valle, C. & Feldman, J. L. NMDA receptors in preBotzinger complex neurons can drive respiratory rhythm independent of AMPA receptors. J. Physiol 582, 359\u201368 (2007).","journal-title":"J. Physiol"},{"key":"41849_CR18","doi-asserted-by":"publisher","unstructured":"Lancaster, E. et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann. Neurol., https:\/\/doi.org\/10.1002\/ana.22297 (2011).","DOI":"10.1002\/ana.22297"},{"key":"41849_CR19","doi-asserted-by":"publisher","first-page":"14874","DOI":"10.1523\/JNEUROSCI.0721-14.2014","volume":"34","author":"UBS Hedrich","year":"2014","unstructured":"Hedrich, U. B. S. et al. Impaired action potential initiation in GABAergic interneurons causes hyperexcitable networks in an epileptic mouse model carrying a human Na(V)1.1 mutation. J. Neurosci. 34, 14874\u201389 (2014).","journal-title":"J. Neurosci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41849-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41849-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41849-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:22:08Z","timestamp":1671265328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41849-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["41849"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-41849-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,3]]},"assertion":[{"value":"31 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5591"}}